Pluri (PLUR) Operating Expenses (2010 - 2025)
Pluri (PLUR) posted quarterly Operating Expenses of $2.7 million for Q4 2025, up 622.4% year-over-year from $368080.2 in Q4 2024, and up 6.11% quarter-over-quarter from $2.5 million in Q3 2025.
Pluri (PLUR) Operating Expenses (2010 - 2025) Analysis & Trends
Pluri (PLUR) has reported Operating Expenses for 16 consecutive years, with $2.7 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Operating Expenses rose 622.4% year-over-year to $2.7 million; the TTM figure through Dec 2025 stood at $17.5 million (up 26.13% YoY), while the FY2025 annual figure was $9.8 million, up 30.64% from the prior year.
- Operating Expenses grew to $2.7 million in Q4 2025 per PLUR's latest filing, from $2.5 million in the prior quarter.
- Across five years, Operating Expenses topped out at $15.1 million in Q2 2021 and bottomed at -$509000.0 in Q4 2024.
- Historically, Operating Expenses has averaged $7.1 million across 5 years, with a median of $6.8 million in 2022.
- Annual changes were most pronounced in 2024 — Operating Expenses plunged 108.8% — and 2025, when it surged 622.4%.
- Pluri's Operating Expenses stood at $10.8 million in 2021, then plunged by 38.11% to $6.7 million in 2022, then retreated by 13.4% to $5.8 million in 2023, then slumped by 108.8% to -$509000.0 in 2024, then soared by 622.4% to $2.7 million in 2025.
- Business Quant data shows PLUR's Operating Expenses at $2.7 million in Q4 2025, $2.5 million in Q3 2025, and $6.8 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.06 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 427.03 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 541.02 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -784.57 Mn |
| 10 | Pluri | 16.11 Mn | 3.63 Mn | 86,000.00 | 2.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.66 Mn |
| Sep 30, 2025 | 2.51 Mn |
| Jun 30, 2025 | 6.83 Mn |
| Mar 31, 2025 | 5.54 Mn |
| Dec 31, 2024 | -509,000.00 |
| Sep 30, 2024 | 2.83 Mn |
| Jun 30, 2024 | 5.96 Mn |
| Mar 31, 2024 | 5.62 Mn |
| Dec 31, 2023 | 5.79 Mn |
| Sep 30, 2023 | 5.80 Mn |
| Jun 30, 2023 | 7.13 Mn |
| Mar 31, 2023 | 7.66 Mn |
| Dec 31, 2022 | 6.68 Mn |
| Sep 30, 2022 | 7.01 Mn |
| Jun 30, 2022 | 8.69 Mn |
| Mar 31, 2022 | 10.71 Mn |
| Dec 31, 2021 | 10.80 Mn |
| Sep 30, 2021 | 11.48 Mn |
| Jun 30, 2021 | 15.05 Mn |
| Mar 31, 2021 | 14.23 Mn |